‘The Outlast Trials’ Spookily Dominates PC Game Sales | Chart

The brand-new horror title was beaten only by the free-to-play title “Counter-Strike: Global Offensive”

The brand-new horror title in the “Outlast” series, “The Outlast Trials,” took the top spot for paid releases with a launch price tag of $30 — according to the weekly Steam charts, which reveals games sold best on Valve’s overwhelmingly dominant PC game distribution platform. “The Outlast Trials” was beaten only in sales volume by the free-to-play title “Counter-Strike: Global Offensive.”

Though it’s not the heart of October’s spooky season, that time of year when horror game sales ramp up as people get festive, it hasn’t stopped “The Outlast Trials” from capitalizing on the series’ long-running name brand power. The series kicked off in 2013 with the PC version of “Outlast,” followed by a sequel in 2017. By 2018, the games had sold over 15 million units across all platforms, a big number for an indie studio.

Become a member to read more.

Robert Carnevale

Robert has covered the technology and entertainment sectors for nearly a decade. He's written for Wired and Tom's Guide as well as served as the news editor for Windows Central. He's also the author of Earth: Game of the Year Edition and Cold War 2395, two science fiction novels that have set the bar for what he's willing to constructively contribute to the world. | Contact: robert.carnevale@thewrap.com